Clinical Trials Logo

Osteoarthritis clinical trials

View clinical trials related to Osteoarthritis.

Filter by:

NCT ID: NCT02805855 Completed - Clinical trials for Osteoarthritis, Knee

Autologous Culture Expanded Mesenchymal Stromal Cells for Knee Osteoarthritis

Start date: October 26, 2016
Phase: Phase 1
Study type: Interventional

The study seeks to determine the safety and feasibility of using adipose-derived mesenchymal stromal cells to treat symptoms of mild to severe knee osteoarthritis.

NCT ID: NCT02803307 Completed - Clinical trials for Osteoarthritis of the Knee

Single-Dose Administration Trial of TLC599 in Osteoarthritis of the Knee

Start date: June 2015
Phase: Phase 1/Phase 2
Study type: Interventional

This trial is a multi-site, randomized, open-label, parallel, and single-dose administration study to investigate the safety and efficacy of TLC599 in subjects with osteoarthritis of the knee.

NCT ID: NCT02802878 Completed - Knee Osteoarthritis Clinical Trials

Combined Application of Electrical Stimulation and Volitional Contractions for Muscle Strengthening and Knee Pain Inhibition (Seated Study)

Start date: June 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the efficacy of a 12-week low-load neuromuscular electrical stimulation with volitional contraction (NMES-VC) training program to improve quadriceps strength and activation, while not adversely affecting knee-related pain, activities of daily living or quality of life in women with knee pain. The primary outcome will be change in maximal isokinetic knee extensor torque. The investigators will test the following hypotheses. In comparison with low-load (40%) resistance training without electrical stimulation, a 12-week NMES-VC training program will: Hypothesis 1: Increase maximal isokinetic knee extensor torque Secondary questions and response variables Hypothesis 2: Not adversely affect knee pain or quality of life, assessed by the Knee injury and Osteoarthritis Outcome Score (KOOS) questionnaire Additional hypotheses in women with risk factors for incident symptomatic or progressive KOA: 1. Determine the extent to which NMES-VC-enhanced low-intensity resistance training increases quadriceps muscle rate of force development 2. Determine the extent to which NMES-VC enhanced low-intensity exercise is tolerated (using numeric rating scale survey "level of pain you experienced during the hybrid training or 40% isokinetic exercise") 3. Determine the extent to which NMES-VC-enhanced low-intensity resistance training increases physical function (20m walk, chair stand)

NCT ID: NCT02802709 Completed - Osteoarthritis Clinical Trials

A Trial of SB-061 in Osteoarthritis of the Knee

MODIFY-OA
Start date: May 2016
Phase: Phase 1/Phase 2
Study type: Interventional

This study evaluates a novel agent, SB-061, for the treatment of osteoarthritis of the knee. Half of the patients will receive the agent via intra-articular injection and half will receive a placebo injection.

NCT ID: NCT02802085 Completed - Clinical trials for Rheumatoid Arthritis

VEGA Prospective Kiel

Start date: May 2016
Phase:
Study type: Observational

Voluntary Post-Marketing Clinical Follow-up (PMCF) as part of the post marketing surveillance plan for the product under investigation. For this PMCF only CE-marked medical devices have been used and will be used within their intended purpose and no additional invasive or other stressful examinations have been or are to be carried out (acc. to MPG §23b).

NCT ID: NCT02801019 Completed - Osteoarthritis Clinical Trials

Vitamin E-Diffused Highly Cross-Linked Polyethylene Liner

Start date: June 2008
Phase: N/A
Study type: Interventional

Vitamin E incorporated highly cross linked polyethylene (E-XLPE) was developed to increase oxidative resistance of highly cross-linked polyethylene (XLPE) without affecting mechanical properties. The investigators evaluated this type of polyethylene in a randomized clinical study, using Radiostereometric Analysis (RSA). The objective of this study was to compare the early-term wear of E-XLPE to a compression annealed polyethylene liner (C-XLPE, ArComXL®). The clinical outcome at two years was not expected to be affected by the choice of polyethylene.

NCT ID: NCT02794740 Completed - Osteoarthritis Clinical Trials

Study of X0002 Following Escalating Single and Multiple Doses Administered as Topical Application in Healthy Volunteers

Start date: June 2016
Phase: Phase 1
Study type: Interventional

Primary Objectives: To evaluate the safety and tolerability of escalating single and multiple doses of X0002 administered as a topical application. Secondary Objectives: To characterize the single and and multiple pharmacokinetics of escalating doses of X0002 and its active metabolite ibuprofen as a topical application.

NCT ID: NCT02790723 Completed - Clinical trials for Osteoarthritis, Knee

Safety of Intra-Articular Sc-rAAV2.5IL-1Ra in Subjects With Moderate Knee OA

AAVIL-1Ra
Start date: June 5, 2019
Phase: Phase 1
Study type: Interventional

This study seeks to determine the safety of three different doses of sc-rAAV2.5IL-1Ra delivered by intra-articular injection into one knee joint of patients with moderate OA of the knee.

NCT ID: NCT02789852 Completed - Hand Injuries Clinical Trials

Evaluation of the Effectiveness of Night Orthosis in Treating Women With Symptomatic Osteoarthritis in the Interphalangeal Joint of the Dominant Hand

Start date: May 30, 2016
Phase: N/A
Study type: Interventional

Evaluation of the effectiveness of using a night orthosis for II and III or fingers of the dominant hand in women diagnosed with symptomatic osteoarthritis compared to a control group.

NCT ID: NCT02786121 Completed - Hip Osteoarthritis Clinical Trials

The Role of Kinesiophobia in the Functional Recovery After Hip Replacement

kinesiofob
Start date: April 2016
Phase: N/A
Study type: Observational

Several authors explain as the kinesiophobia plays an important role for the recovery after orthopaedic surgery. The aim of the investigators study is to investigate if the kinesiophobia is able to influence the early recovery after total hip arthroplasty. The early recovery will be measured by the ILOA Score. The Tampa Scale of Kinesiophobia will measure the fear level of movement. All the other variable that could influence the ILOA Score are identified and collected: age, sex, body max index, ability of patient pre-surgery, type of anesthesia, length of stay, pain, haemoglobin, possible complications.